论文部分内容阅读
目的观察食道心房调博在妊娠合并阵发性室上性心动过速患者治疗中的有效性及安全性。方法26例妊娠合并阵发性室上性心动过速患者按照其意愿分为静脉推注三磷酸腺苷组与食道心房调搏(TEAP)组,比较2组的转复成功率,并观察其不良反应。结果转复成功率比较,TEAP组为100%(12例全部转复成功),三磷酸腺苷组为71.43%(10例转复成功),其余4例经食道心房调搏转复成功,三磷酸腺苷组患者出现不同程度呼吸困难,甚至濒死感,患者耐受差。结论食道心房调博终止阵发性室上性心动过速效果较三磷酸腺苷好,且不良反应小。
Objective To observe the efficacy and safety of esophageal atrial function in the treatment of patients with paroxysmal supraventricular tachycardia during pregnancy. Methods Twenty-six patients with pregnancy complicated with paroxysmal supraventricular tachycardia were divided into three groups according to their wishes: intravenous infusion of adenosine triphosphate (ATP) group and esophageal atrial pacing group (TEAP). The success rate of the two groups were compared and their adverse reactions were observed. Results The successful rate of transposition was 100% in TEAP group (all 12 cases were successfully transfered), 71.43% in adenosine triphosphate group (10 cases succeeded in transplanting), and the other 4 cases transplanted transepithelial transthoracic esophageal successfully. Patients in adenosine triphosphate group Different levels of dyspnea, or even near-sense, poor patient tolerance. Conclusions Esophageal atrial fibrillation booster paroxysmal supraventricular tachycardia than adenosine triphosphate, and adverse reactions small.